Johnson & Johnson suffers setback over stent litigation decisions
This article was originally published in Clinica
Executive Summary
Johnson & Johnson has been dealt a blow after one ruling in its favour in stent-related litigation was overturned and, in a separate dispute concerning stents, a retrial into damages was ordered. Damages totalling $595.5 million have been set aside.